What is the address of MEDIBAT?

The registered office of MEDIBAT is located at Cl du Ch d'Abeiche 11, 1420 Braine-l'Alleud.

Is MEDIBAT still active?

Yes. According to the CBE (29 October 2026) MEDIBAT is active, legal situation “Normale toestand”, started on 10 December 1992.

Is MEDIBAT registered on Peppol?

Yes, MEDIBAT is registered on the Peppol network with ID 0208:0448812565.

What is the enterprise number of MEDIBAT?

The enterprise number of MEDIBAT is BE0448812565.

When was MEDIBAT founded?

MEDIBAT was founded on 10 December 1992.

Who are the directors of MEDIBAT?

According to the 2025 annual accounts, the directors of MEDIBAT are: Jean-Marie Couet, Vincent Couet.

Is MEDIBAT a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 10 December 1992; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did MEDIBAT make in 2025?

MEDIBAT recorded a loss after taxes of € 172,791 in financial year 2025.

What is the revenue of MEDIBAT?

As a small company, MEDIBAT is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € -147,567.

MEDIBAT (Public Limited) - Braine-l'Alleud - BE0448812565

Q: What does MEDIBAT do?

MEDIBAT is registered with the CBE as active in: Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies. Public Limited, started on 10 December 1992, 1 establishment.

Dossier MEDIBAT, printed on 29 October 2026 from databakkes.be/en/0448812565/medibat. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 6 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

MEDIBAT from Braine-l'Alleud, company number BE0448812565, closed financial year 2025 with a result of € -172,791 after tax. For that financial year MEDIBAT recorded a gross margin of € -147,567 and equity of € 199,742. Compared with financial year 2024, the result moved from € 144,612 to € -172,791. The company made a loss. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on August 10, 2026.

What it is worth Healthy

€ 199,742

▼ 46% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -172,791

▼ still € 144,612 profit in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 16,017

▼ 90% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 134,480.

People and assets in 2025

Wage cost

€ 3,640

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 1,277

▼ 27% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 4 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 1.6 million

▲ 136% vs 2024

€ 405,180 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.

Owed to suppliers

€ 120

▼ € 52,994 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 13,909

▼ 56% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 94,655 Gross margin 2022: € 94,655 First fiscal year in the series	€ 239,666 Gross margin 2023: € 239,666 ▲ 153% vs 2022 (€ 94,655) Favourable step	€ 260,104 Gross margin 2024: € 260,104 ▲ 9% vs 2023 (€ 239,666) Favourable step	€ -147,567 Gross margin 2025: € -147,567 ▼ € 407,672 vs 2024 (€ 260,104) Unfavourable step	▼ € 407,672
Profit after taxes	€ -30,836 Profit after taxes 2022: € -30,836 First fiscal year in the series	€ 62,297 Profit after taxes 2023: € 62,297 ▲ € 93,133 vs 2022 (€ -30,836) Favourable step	€ 144,612 Profit after taxes 2024: € 144,612 ▲ 132% vs 2023 (€ 62,297) Favourable step	€ -172,791 Profit after taxes 2025: € -172,791 ▼ € 317,403 vs 2024 (€ 144,612) Unfavourable step	▼ € 317,403
Equity	€ 165,624 Equity 2022: € 165,624 First fiscal year in the series	€ 227,921 Equity 2023: € 227,921 ▲ 38% vs 2022 (€ 165,624) Favourable step	€ 372,533 Equity 2024: € 372,533 ▲ 63% vs 2023 (€ 227,921) Favourable step	€ 199,742 Equity 2025: € 199,742 ▼ 46% vs 2024 (€ 372,533) Unfavourable step	▼ 46%
Total debts	€ 1,506,750 Total debts 2022: € 1,506,750 First fiscal year in the series	€ 986,262 Total debts 2023: € 986,262 ▼ 35% vs 2022 (€ 1,506,750) Favourable step	€ 801,042 Total debts 2024: € 801,042 ▼ 19% vs 2023 (€ 986,262) Favourable step	€ 2,050,619 Total debts 2025: € 2,050,619 ▲ 156% vs 2024 (€ 801,042) Unfavourable step	▲ 156%
Cash	€ 3,238 Cash 2022: € 3,238 First fiscal year in the series	€ 48,517 Cash 2023: € 48,517 ▲ € 45,279 vs 2022 (€ 3,238) Favourable step	€ 154,580 Cash 2024: € 154,580 ▲ 219% vs 2023 (€ 48,517) Favourable step	€ 16,017 Cash 2025: € 16,017 ▼ 90% vs 2024 (€ 154,580) Unfavourable step	▼ 90%
Land & buildings	€ 977,175 Land & buildings 2022: € 977,175 First fiscal year in the series	€ 491,587 Land & buildings 2023: € 491,587 ▼ 50% vs 2022 (€ 977,175) Unchanged	€ 547,438 Land & buildings 2024: € 547,438 ▲ 11% vs 2023 (€ 491,587) Unchanged	€ 1,274,049 Land & buildings 2025: € 1,274,049 ▲ 133% vs 2024 (€ 547,438) Unchanged	▲ 133%
Retained profit	€ 100,363 Retained profit 2022: € 100,363 First fiscal year in the series	€ 162,659 Retained profit 2023: € 162,659 ▲ 62% vs 2022 (€ 100,363) Favourable step	€ 307,271 Retained profit 2024: € 307,271 ▲ 89% vs 2023 (€ 162,659) Favourable step	€ 134,480 Retained profit 2025: € 134,480 ▼ 56% vs 2024 (€ 307,271) Unfavourable step	▼ 56%
Bank debt	€ 1,290,222 Bank debt 2022: € 1,290,222 First fiscal year in the series	€ 762,768 Bank debt 2023: € 762,768 ▼ 41% vs 2022 (€ 1,290,222) Favourable step	€ 669,792 Bank debt 2024: € 669,792 ▼ 12% vs 2023 (€ 762,768) Favourable step	€ 1,580,909 Bank debt 2025: € 1,580,909 ▲ 136% vs 2024 (€ 669,792) Unfavourable step	▲ 136%
Balance sheet total	€ 1,702,278 Balance sheet total 2022: € 1,702,278 First fiscal year in the series	€ 1,258,156 Balance sheet total 2023: € 1,258,156 ▼ 26% vs 2022 (€ 1,702,278) Unchanged	€ 1,254,640 Balance sheet total 2024: € 1,254,640 Unchanged (€ 1,258,156) Unchanged	€ 2,268,401 Balance sheet total 2025: € 2,268,401 ▲ 81% vs 2024 (€ 1,254,640) Unchanged	▲ 81%

Key figures of MEDIBAT, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to MEDIBAT?

What happened at MEDIBAT in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 10, 2026 New annual accounts for financial year 2025: loss of € 172,791 (▼ € 317,403 vs 2024). filed late Source: NBB ↗
2023 Jean-Marie Couet stepped down as director. NBB
2023 Vincent Couet stepped down as director. NBB
2017 Jean-Marie Couet became a director. NBB
2017 Vincent Couet became a director. NBB
Dec 14, 1992 New establishment in Braine-l'Alleud. KBO
Dec 10, 1992 Start of the company according to the CBE. KBO

In short

From € 30,836 loss in 2022 to € 172,791 loss in 2025.

Paid € 28,909 in corporate taxes since 2022.

Best year ever: 2024, with € 144,612 profit.

Original PDFs at the National Bank ↗

Management

MEDIBAT

Chateau d'Or 100%

It owns 100% of Chateau d'Or itself.

Directors

According to the 2025 annual accounts

Jean-Marie Couet

Managing director

since 2017 · until 2023

Vincent Couet

Director

Also active at: AB-BROKERS, CHATEAU D'OR, AROUND, Parte, PARTE EXPERT, LES CRÉAS DE XAV, Antomax Air Conditionning, EMBOURIMMO +3 more

since 2017 · until 2023

Establishments

Establishment units

Physical locations of this company

Registered office

Cl du Ch d'Abeiche 11

1420 Braine-l'Alleud

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.

All companies at this address →

CHATEAU D'OR same network

€ 89,723 gross margin · 2025

LES CRÉAS DE XAV same network

€ -11,210 gross margin · 2025

Belgian Emirates Trading same network

€ -4,191 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0448.812.565

VAT number

BE 0448.812.565

Registered office

Cl du Ch d'Abeiche 11, 1420 Braine-l'Alleud

Names & denominations

MEDIBAT

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

10 December 1992

Peppol

Active · Active since 22 Dec 2025

Activities · NACE

Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies

Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering

View on CBE Public ↗ Annual accounts (NBB) ↗

MEDIBAT

Warning lights

Financials

What happened to MEDIBAT?

Management

Directors

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions